Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biospecifics Technologies Corp (NASDAQ:BSTC)

37.21
Delayed Data
As of 4:00pm ET
 +0.23 / +0.62%
Today’s Change
30.70
Today|||52-Week Range
63.20
-13.40%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$259.3M

Company Description

BioSpecifics Technologies Corp. is a biopharmaceutical company, which engages in development of an injectable collagenase for multiple indications. Its product XIAFLEX is an injectable collagenase enzyme, which is used for the treatment of Dupuytren's contracture in adults with a palpable cord in the palm. The company was founded in 1990 and is headquartered in Lynbrook, NY.

Contact Information

Biospecifics Technologies Corp.
35 Wilbur Street
Lynbrook New York 11563
P:(516) 593-7000
Investor Relations:

Employees

Shareholders

Individual stakeholders37.23%
Other institutional35.73%
Mutual fund holders20.81%

Top Executives

Thomas L. WegmanPresident, CEO, CFO, Director & CAO
James GorisController